Cognitive and behavioral impact of the ketogenic diet in children and adolescents with refractory epilepsy: A

Dominique M IJff1, Debby Postulart2, Danielle A J E Lambrechts3

  • 1Department of Behavioral Sciences, Epilepsy Center Kempenhaeghe, Heeze, The Netherlands; MHENS School of Mental Health & Neuroscience, Maastricht University, Maastricht, The Netherlands.

Insights

The ketogenic diet (KD) positively impacts behavior and cognition in children with refractory epilepsy. This study found improved mood, reduced anxiety, and enhanced cognitive function in children on the KD.

Area of Science:

  • Pediatric Neurology
  • Neuroscience
  • Clinical Nutrition

Background:

  • Refractory epilepsy in childhood is a significant clinical challenge.
  • The ketogenic diet (KD) is recognized for its efficacy in seizure reduction.
  • Objective assessment of KD's cognitive and behavioral effects is crucial.

Purpose of the Study:

  • To evaluate the impact of the ketogenic diet (KD) on cognitive and behavioral outcomes in children and adolescents with refractory epilepsy.
  • To compare these outcomes between a KD group and a care-as-usual (CAU) control group.
  • To assess changes within the first four months of KD initiation.

Main Methods:

  • A randomized controlled trial was conducted with pediatric epilepsy patients.
  • Participants were assigned to either the KD intervention group or the CAU control group.
  • Cognition and behavior were assessed at four months using parent questionnaires and psychological tests.

Main Results:

  • The KD group (n=28) demonstrated lower levels of anxious and mood-disturbed behaviors compared to the CAU group (n=22).
  • Children in the KD group were rated as more productive.
  • Cognitive testing revealed improved activation in the KD group.

Conclusions:

  • The ketogenic diet (KD) shows a positive effect on behavioral and cognitive functioning in pediatric refractory epilepsy.
  • Specifically, KD treatment was associated with enhanced mood and cognitive activation.
  • These findings support the use of KD for improving overall functioning in this population.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
315
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
1.9K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.6K